Torthaí cuardaigh - "Treatment-resistant depression"

  • 1 - 14 toradh as 14 á dtaispeáint
Beachtaigh na torthaí
  1. 1

    Fixed dose combination dextromethorphan-bupropion: A hope for treatment resistant depression (TRD) de réir Ranjan Das, Rajarshi Chakravarty, Varaha V. Gantait, Subir Bhattacharjee

    Foilsithe / Cruthaithe 2025-06-01

    Background: Treatment resistant depression (TRD) has been identified as non-response to depression with adequate dose and trial of two antidepressant medications of different classes. Near about 30% depressive patients are TRD cases. Olanzapine‐fluoxetine combination, rTMS, Intravenous ketamine and...

    Cur síos iomlán

    Ábhair: Faigh an téacs iomlán
    Alt
  2. 2

    A retrospective study of predictive factors for effective aripiprazole augmentation of antidepressant therapy in treatment-resistant depression de réir Sugawara H, Sakamoto K, Harada T, Shimizu S, Ishigooka J

    Foilsithe / Cruthaithe 2016-05-01

    Hiroko Sugawara,1,2 Kaoru Sakamoto,1 Tsuyoto Harada,3 Satoru Shimizu,4 Jun Ishigooka1 1Department of Psychiatry, Tokyo Women’s Medical University, 2Support Center for Women Health Care Professionals and Researchers, Tokyo Women’s Medical University, Shinjuku-ku, 3Departm...

    Cur síos iomlán

    Ábhair: “…Treatment-resistant depression…”
    Faigh an téacs iomlán
    Alt
  3. 3

    Major Depressive Disorder with Suicidal Ideation or Intent in Taiwan: A Discrete Choice Experiment of Psychiatrists’ Treatment Preferences de réir Simon Fifer, Brittany Keen, Keira Joann Herr, Chih-Lin Chiang, Thomas Webb

    Foilsithe / Cruthaithe 2025-04-01

    Objective: In this study, we intended to understand how psychiatrists in Taiwan value different attributes of pharmacological treatments for major depressive disorder with suicidal ideation or intent (MDSI). Novel therapies for MDSI differ from standard treatments in their route of administration, e...

    Cur síos iomlán

    Ábhair: Faigh an téacs iomlán
    Alt
  4. 4

    Insomnia and Esketamine Add-On Therapy to Antidepressant Therapy in Patients with Treatment-Resistant Depression—A Pilot Study de réir Daniel Szawarnoga, Joanna Fojcik, Michał Górski, Artur Pałasz, Marek Krzystanek

    Foilsithe / Cruthaithe 2025-07-01

    <b>Background:</b> Insomnia, as one of the most common sleep disorders, is a significant health problem, especially among patients suffering from drug-resistant depression. Problems related to the quality of sleep in that population can significantly affect the effectiveness of treatment...

    Cur síos iomlán

    Ábhair: Faigh an téacs iomlán
    Alt
  5. 5

    Symptom networks in major depressive disorder and treatment response: special focus on TRD de réir Alexander Kautzky, Lucie Bartova, Markus Dold, Daniel Souery, Stuart Montgomery, Joseph Zohar, Julien Mendlewicz, Chiara Fabbri, Alessandro Serretti, Evgenii Tretiakov, Dan Rujescu, Tibor Harkany, Siegfried Kasper

    Foilsithe / Cruthaithe 2025-01-01

    Abstract Background Heterogeneous symptoms in major depression contribute to unsuccessful antidepressant treatment, termed treatment-resistant depression (TRD). Psychometric network modeling conceptualizes depression as interplay of symptoms with potential benefits for treatment; however, a knowledg...

    Cur síos iomlán

    Ábhair: Faigh an téacs iomlán
    Alt
  6. 6

    Longitudinal associations between psychological factors, community integration, and suicide risks among patients with treatment-resistant depression in Vietnam de réir Pham Thi Thu Huong, Chia-Yi Wu, Chia-Yi Wu, Chia-Yi Wu, Chia-Yi Wu, Lee Ming Been, Nguyen Van Tuan, Nguyen Van Tuan, Pham Thi Thu Hien, Pham Thi Thu Hien, Nguyen Thi Lan Anh, Nguyen Thi Son, Nguyen Thi Son, Nguyen Thi Thu Hien, Nguyen Thi Thu Hien

    Foilsithe / Cruthaithe 2025-07-01

    ObjectiveTo examine longitudinal associations of psychological distress, community integration, suicide ideation, and attempts within 3-month post-discharge period among patients with treatment-resistant depression (TRD).MethodsProspective study design with a 3-month followed-up from the hospital ad...

    Cur síos iomlán

    Ábhair: “…treatment-resistant depression…”
    Faigh an téacs iomlán
    Alt
  7. 7

    Non-24-hour sleep&amp;ndash;wake syndrome improved by low-dose valproic acid: a case report de réir Kurita M, Moriya T, Nishino S, Hirata E, Hirasawa N, Okubo Y, Sato T

    Foilsithe / Cruthaithe 2016-12-01

    Masatake Kurita,1&amp;ndash;3 Takahiro Moriya,2 Satoshi Nishino,2,4 Eishin Hirata,4 Noriyasu Hirasawa,5 Yoshiro Okubo,3 Tadahiro Sato4 1Wakamiya Hospital, Koutokukai, Yoshihara, Yamagata, 2Department of Cellular Signaling, Graduate School of Pharmaceutical Sciences, Tohoku University, Sendai, M...

    Cur síos iomlán

    Ábhair: Faigh an téacs iomlán
    Alt
  8. 8

    Shaping the Future of Psychiatric Neurosurgery: From Connectomic Precision to Technological Integration de réir Cristina V. Torres Díaz, Marta Navas García, Paloma Pulido Rivas, Mónica Lara Almunia, José Antonio Fernández Alén

    Foilsithe / Cruthaithe 2025-06-01

    Psychiatric neurosurgery is undergoing a profound transformation, propelled by advances in neurotechnology, connectomics, and personalized medicine. Once controversial, surgical interventions are now guided by detailed functional brain mapping and precise neuromodulation techniques, such as deep bra...

    Cur síos iomlán

    Ábhair: Faigh an téacs iomlán
    Alt
  9. 9

    Pharmacokinetics, Safety, and Tolerability of (R)-Ketamine Hydrochloride Injection, a Novel Rapid-Acting Antidepressant, in Healthy Chinese Subjects de réir Rui Wang, Yuqian Yang, Tong Zhou, Bingjie Zou, Li Ding

    Foilsithe / Cruthaithe 2025-07-01

    <b>Objectives</b>: (R)-ketamine hydrochloride injection is a novel, rapid-acting antidepressant for the treatment of treatment-resistant depression. The aim of this study was to assess the pharmacokinetics, safety, and tolerability of (R)-ketamine hydrochloride injection in healthy Chine...

    Cur síos iomlán

    Ábhair: Faigh an téacs iomlán
    Alt
  10. 10

    Cost-per-remitter for esketamine nasal spray versus quetiapine for treatment-resistant depression de réir Kristin Clemens, Amanda Teeple, Benoit Rive, Noam Kirson, Urvi Desai, Jason Doran, Diab Eid, Alice Qu, Hannah Bowrey, Kruti Joshi

    Foilsithe / Cruthaithe 2025-06-01

    Aim: Estimate the cost-per-remitter with esketamine nasal spray plus an oral antidepressant (ESK NS + OAD) versus quetiapine extended release plus an oral antidepressant (QTP XR + OAD) among adults with treatment-resistant depression (TRD). Materials & methods: An Excel-based model was develop...

    Cur síos iomlán

    Ábhair:
    Alt
  11. 11

    Comorbid medical illness as a predisposing factor for the treatment-resistant depression. Part 1: Mechanisms of treatment resistance de réir M. Yu. Popov

    Foilsithe / Cruthaithe 2018-07-01

    Management of treatment-resistant depression is one of the most important problems in modern psychiatry. Comorbidity of depression with medical diseases is one of the predisposing factors for the development of treatment resistance due to various mechanisms, including genetic, endocrine, neuroimmune...

    Cur síos iomlán

    Ábhair: Faigh an téacs iomlán
    Alt
  12. 12

    Comorbid medical illness as a predisposing factor for the treatment-resistant depression. Part 2: Principles of rational use of antidepressants in general medical practice de réir M. Yu. Popov, V. L. Kozlovskiy

    Foilsithe / Cruthaithe 2018-07-01

    Given the differences in the pharmacological and clinical effects of antidepressants, criteria for their differential choice in the treatment of depression associated with comorbid medical illnesses are suggested. Based on these criteria and general rules of clinical pharmacology, principles of anti...

    Cur síos iomlán

    Ábhair: Faigh an téacs iomlán
    Alt
  13. 13

    Nutraceutical eicosapentaenoic acid in treatment-resistant depression: The psychoneuroimmunity and clinical implications de réir Jane Pei-Chen Chang, Ayesha Zafar Iqbal, Quang Le Do, Muhammad Yaseen, Suet-Kei Wu, Ikbal Andrian Malau, Halliru Zailani, Kuan-Pin Su

    Foilsithe / Cruthaithe 2025-08-01

    Treatment Resistant Depression is characterized by inadequate response to at least two adequate trials of antidepressants, highlighting the need for alternative or adjunctive strategies. Emerging evidence suggests omega-3 polyunsaturated fatty acids, particularly eicosapentaenoic acid, may offer the...

    Cur síos iomlán

    Ábhair: Faigh an téacs iomlán
    Alt
  14. 14

    Resource utilization and economic outcomes following repetitive transcranial magnetic stimulation for treatment-resistant depression: a retrospective observational analysis de réir Joseph J Taylor, Andrew J Manett, Michael Feyder, Brandon S Bentzley

    Foilsithe / Cruthaithe 2025-01-01

    Aim: We investigated the impact of repetitive transcranial magnetic stimulation (rTMS) for treatmentresistant depression on healthcare resource utilization as well as commercial and Medicare Fee-for-Service payer costs. Materials & methods:We conducted a retrospective observational analysis of...

    Cur síos iomlán

    Ábhair:
    Alt